REGN vs MRNA: Which Stock is Better?
Side-by-side comparison of Regeneron Pharmaceuticals Inc and Moderna Inc in 2026
REGN
Regeneron Pharmaceuticals Inc
$781.67
MRNA
Moderna Inc
$53.57
Key Metrics Comparison
| Metric | REGN | MRNA | Winner |
|---|---|---|---|
| Market Cap | $82.64B | $20.93B | REGN |
| P/E Ratio | 18.83 | N/A | REGN |
| EPS (TTM) | $41.51 | $N/A | REGN |
| Revenue Growth | 0.0% | -0.3% | REGN |
| Gross Margin | 44.6% | -105.8% | REGN |
Analyze REGN
Full quant analysis
Analyze MRNA
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REGN or MRNA a better investment?
Comparing REGN and MRNA: Regeneron Pharmaceuticals Inc has a market cap of $82.64B while Moderna Inc has $20.93B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REGN and MRNA?
REGN (Regeneron Pharmaceuticals Inc) and MRNA (Moderna Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REGN or MRNA?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: REGN or MRNA?
REGN has higher revenue growth at 0.0% vs -0.3% for MRNA.
Which company is more profitable: REGN or MRNA?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -105.8% for MRNA.
Which is the larger company: REGN or MRNA?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $82.64B compared to $20.93B for MRNA.
Should I buy REGN or MRNA in 2026?
Both REGN and MRNA have investment merit. REGN trades at $781.67 while MRNA trades at $53.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REGN and MRNA stock?
Key differences: Market Cap ($82.64B vs $20.93B), P/E Ratio (18.8x vs N/A), Revenue Growth (0.0% vs -0.3%), Gross Margin (44.6% vs -105.8%).